Tags

Type your tag names separated by a space and hit enter

Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema.
Int Angiol. 2012 Aug; 31(4):310-5.IA

Abstract

AIM

The aim of this study was to compare the reduction of venous ankle edema in randomized controlled trials of the main venoactive drugs versus a placebo or versus another venoactive drug and thereby to confirm or invalidate the existing recommendations on the pharmacological treatment of venous edema.

METHODS

Publications of randomized controlled trials of venoactive drugs versus either a placebo or another venoactive drug on the reduction of ankle circumferences (AC) were searched through Medline and selected according to the Jadad and the Cucherat evaluation grids.

RESULTS

Ten publications dated between 1975 and 2009 including a total of 1010 patients were identified for the meta-analysis. Included were the following venoactive drugs: micronised purified flavonoid fraction (MPFF), hydroxyethylrutoside, ruscus extracts and diosmin. The mean reduction in AC was -0.80 ± 0.53 cm with MPFF , -0.58 ± 0.47 cm with ruscus extract, -0.58 ± 0.31 cm with hydroxyethylrutoside, -0.20 ± 0.5 cm with single diosmin, and -0.11 ± 0.42 cm with placebo. The reduction in AC was significantly superior to that of placebo whatever the drug concerned (P<0.0001). The comparison between MPFF, ruscus extract and hydroxyethylrutoside on the reduction of ankle edema was in favour of MPFF. This was significant (P<0.0001), while the efficacy of the latter two venoactive agents was comparable.

CONCLUSION

This meta-analysis confirms the validity of the grade A assigned to MPFF in the management of symptoms and edema in recent international guidelines.

Authors+Show Affiliations

Ceren ESC and Dijon University Hospital, Dijon, France. allaert@cenbiotech.com

Pub Type(s)

Journal Article
Meta-Analysis
Review

Language

eng

PubMed ID

22801396

Citation

Allaert, F A.. "Meta-analysis of the Impact of the Principal Venoactive Drugs Agents On Malleolar Venous Edema." International Angiology : a Journal of the International Union of Angiology, vol. 31, no. 4, 2012, pp. 310-5.
Allaert FA. Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema. Int Angiol. 2012;31(4):310-5.
Allaert, F. A. (2012). Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema. International Angiology : a Journal of the International Union of Angiology, 31(4), 310-5.
Allaert FA. Meta-analysis of the Impact of the Principal Venoactive Drugs Agents On Malleolar Venous Edema. Int Angiol. 2012;31(4):310-5. PubMed PMID: 22801396.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema. A1 - Allaert,F A, PY - 2012/7/18/entrez PY - 2012/7/18/pubmed PY - 2012/12/10/medline SP - 310 EP - 5 JF - International angiology : a journal of the International Union of Angiology JO - Int Angiol VL - 31 IS - 4 N2 - AIM: The aim of this study was to compare the reduction of venous ankle edema in randomized controlled trials of the main venoactive drugs versus a placebo or versus another venoactive drug and thereby to confirm or invalidate the existing recommendations on the pharmacological treatment of venous edema. METHODS: Publications of randomized controlled trials of venoactive drugs versus either a placebo or another venoactive drug on the reduction of ankle circumferences (AC) were searched through Medline and selected according to the Jadad and the Cucherat evaluation grids. RESULTS: Ten publications dated between 1975 and 2009 including a total of 1010 patients were identified for the meta-analysis. Included were the following venoactive drugs: micronised purified flavonoid fraction (MPFF), hydroxyethylrutoside, ruscus extracts and diosmin. The mean reduction in AC was -0.80 ± 0.53 cm with MPFF , -0.58 ± 0.47 cm with ruscus extract, -0.58 ± 0.31 cm with hydroxyethylrutoside, -0.20 ± 0.5 cm with single diosmin, and -0.11 ± 0.42 cm with placebo. The reduction in AC was significantly superior to that of placebo whatever the drug concerned (P<0.0001). The comparison between MPFF, ruscus extract and hydroxyethylrutoside on the reduction of ankle edema was in favour of MPFF. This was significant (P<0.0001), while the efficacy of the latter two venoactive agents was comparable. CONCLUSION: This meta-analysis confirms the validity of the grade A assigned to MPFF in the management of symptoms and edema in recent international guidelines. SN - 1827-1839 UR - https://www.unboundmedicine.com/medline/citation/22801396/full_citation L2 - http://www.minervamedica.it/index2.t?show=R34Y2012N04A0310 DB - PRIME DP - Unbound Medicine ER -